Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Capital Expenditures Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 93.09%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 9.89%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 8.41%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 25.00%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -4.38%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -31.58%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 13.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.89%
Mar 31, 2026 -3.54%
Dec 31, 2025 2.43%
Sep 30, 2025 6.86%
Jun 30, 2025 12.43%
Mar 31, 2025 22.92%
Dec 31, 2024 -5.12%
Sep 30, 2024 6.00%
Jun 30, 2024 3.08%
Mar 31, 2024 6.54%
Dec 31, 2023 -23.69%
Sep 30, 2023 4.89%
Jun 30, 2023 8.24%
Mar 31, 2023 15.23%
Dec 31, 2022 -5.10%
Sep 30, 2022 7.12%
Jun 30, 2022 -3.66%
Mar 31, 2022 10.26%
Dec 31, 2021 -1.57%
Sep 30, 2021 3.19%